ABOUT THIS EPISODE
A rural 340B program is a network of independent contract pharmacies functioning as an extension of the care team, not a single in-house pharmacy counter. Ronnah Alexander, BSPharm, MBA, ACE, who leads the 340B program at Health First Community Health Center in western Kentucky, explains how that model actually runs day to day, and how a device that gets zero 340B discount became one of the highest-impact uses of program savings her clinic has made.
In this episode, Ronnah who's spent 36 years in pharmacy and nearly a decade specifically in 340B walks host Muhammad Atif through what it actually takes to run a rural 340B program: treating contract pharmacies as a real extension of the care team, absorbing growing manufacturer reporting requirements without losing focus on patients, and funding a continuous glucose monitor program entirely out of program savings even though the device itself gets no 340B discount at all. That program helped cut her clinic's uncontrolled diabetic rate from 33 percent to 19 percent in two years.
She's candid about where the program is straining, too: a shrinking charity-care ceiling, the confusion left behind when the 340B rebate model paused, and which patients still fall through the cracks even when the program works exactly as designed. She closes with a direct message for policymakers not a request for more money, but a request for a single, coordinated plan.
Why rural 340B programs depend on independent contract pharmacies instead of in-house pharmacies How a contract pharmacy helped an incarcerated patient complete his Hepatitis C treatment Why keeping a drug's price down can actually push its own 340B price up How a device that gets zero 340B discount cut uncontrolled diabetes nearly in half Which patients are most likely to fall through the cracks even with 340B in place What Ronnah wants policymakers to understand about rural 340B before the next round of restrictions lands
00:00 Introduction to 340B Pulse
00:33 Ronnah Alexander's journey into 340B
06:04 What 340B actually looks like in rural Kentucky
09:08 Contract pharmacies as an extension of the care team 11:32 Handling growing manufacturer compliance requirements 13:31 The 340B rebate model: relief and new confusion
17:29 Patient impact: insulin and chronic disease access
20:43 The CGM program and cutting uncontrolled diabetes in half
25:57 Manufacturer restrictions from the inside
27:51 Transparency, ESP, and duplicate-discount avoidance 29:39 Preparing for the future of 340B
32:15 Ronnah's advice to policymakers
33:20 Rapid fire round 34:22 Closing and how to connect with Ronnah
Why do rural 340B covered entities rely on contract pharmacies?
Because most rural clinic locations don't have enough patient volume to justify the cost of an in-house pharmacy, pharmacist, and technician, so covered entities partner with locally owned independent pharmacies instead.
Does a continuous glucose monitor qualify for a 340B discount?
No a CGM is a device, not a drug, so it receives no 340B discount. Some covered entities fund patient access to CGMs directly out of 340B program savings instead.
What does Ronnah Alexander want policymakers to understand about rural 340B?
That covered entities need one single, coordinated blueprint for how the program should run, instead of a continuous stream of individual manufacturer and policy changes that leave them reacting one at a time with no ability to plan ahead.
